Context Therapeutics Inc. (CNTX) Misses Q3 EPS by 17c

Context Therapeutics Inc. (NASDAQ: CNTX) reported Q3 EPS of ($0.22), $0.17 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Context Therapeutics Inc. (CNTX) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Lantern Pharma (LTRN) files for 2.24M share offering by selling stockholders
• 22nd Century Group files prospectus for warrant share resale